Screenshot 2024-03-06 at 7.16.28 AM


Life Sciences

Watkins-Conti provides immediate relief from stress urinary incontinence (SUI), allowing women to regain their confidence and quality of life.

Why we invested:

Screenshot 2024-03-05 at 3.55.19 PM

Market Need

Nearly 3 out of 4 women worldwide will suffer from stress urinary incontinence, for which there is currently no easy-to-use, non-surgical option.

Yoni.FIt in use

Superior Technology

Watkins-Conti's Yoni.Fit reduced SUI symptoms by at least 50% for 96% of women in a clinical trial. Unlike other devices, it requires no significant time investment or protocol compliance.

Screenshot 2024-03-05 at 4.03.14 PM

Founder & Team

CEO Allison Watkins founded Watkins-Conti after being frustrated by the lack of effective, non-surgical solutions for the stress urinary incontinence she experienced following the birth of her two children. She holds numerous global patents and is supported by an exceptional Advisory Board.

  • "We could not be more pleased to have Boyd Street Ventures as an investor. Their management team and Strategic Advisory Board can be a great source of insight, particularly in the areas of strategy and operations, and they are actively engaged in the honing for success."

  • "James has been extremely helpful in making important introductions for us. I appreciate the fact that he’s always asking me about our plans to grow even faster, and it seems that every time I talk to him he has another great idea for a potential new customer."

  • "BSV is not just a name on our company cap table. They are a valuable business partner as an investor offering strategic guidance and a strong network of industry connections, all of which contribute to our enhanced growth and success."

Question? Just schedule a call with the BSV team.